New scan techniques aim to solve rare heart disease mysteries
NCT ID NCT07336394
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing advanced heart MRI scans to better diagnose and predict risks for people with rare heart muscle diseases. Researchers will scan 1000 participants to see if these new imaging methods can identify conditions like Fabry disease and cardiac amyloidosis more accurately. The goal is to give patients clearer information about their condition and future health risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital
RECRUITINGBeijing, 100037, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver clues: a new way to stage heart amyloidosis?
- Can early enzyme therapy save kidneys in fabry disease?
- Can continued lucerastat access help fabry patients?
- A carpal tunnel clue to a silent heart threat?
- Heart scans may unlock hidden risks in minority communities
- Can a single gene infusion rewrite the story of fabry disease?